Loading...
 
Back to the list
Mediterr J Rheumatol 2017;28(3):164-8
Article Links
Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs
Konstantinos Thomas1, Petros P. Sfikakis2, Dimitrios Boumpas3, Kyriaki Boki4, Dimitrios Vassilopoulos1
Authors Information

1: Joint Rheumatology Program, Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens School of Medicine, Hippokration General Hospital, Athens, Greece

2: Joint Rheumatology Program, 1st Propaedeutic Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Laiko General Hospital, Athens, Greece

3: Joint Rheumatology Program, 4th Department of Medicine, National and Kapodistrian University of Athens School of Medicine, Attikon General Hospital, Athens, Greece

4: Rheumatology Department, Sismanoglio General Hospital, Athens, Greece

Keywords: rheumatoid arthritis, varicella zoster virus, reactivation, immunization
References
  1. Oxman M N, Levin M J, Johnson G R, et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. N Engl J Med 2005;352:2271-84.
  2. Arvin A M. Humoral and Cellular Immunity to Varicella‐Zoster Virus: An Overview. J Infect Dis 2008;197:S58-S60.
  3. Langan S M, Minassian C, Smeeth L, Thomas S L. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis 2014;58:1497-1503.
  4. Calabrese L H, Xie F, Yun H, et al. Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases. Arthritis Rheumatol 2017;69:439-46.
  5. Levin M J, Oxman M N, Zhang J H, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008;197:825-35.
  6. Winthrop K L, Furst D E. Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy. Ann Rheum Dis 2010;69:1735-37.
  7. Rondaan C, de Haan A, Horst G, et al. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. Arthritis Rheumatol (Hoboken, NJ) 2014;66:3122-8.
  8. Smitten A L, Choi H K, Hochberg M C, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 2007;57:1431-8.
  9. Veetil B M A, Myasoedova E, Matteson E L, Gabriel S E, Green A B, Crowson C S. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 2013;65:854-61.
  10. Strangfeld A. Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents. JAMA 2009;301:737.
  11. Galloway J B, Mercer L K, Moseley A, et al. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2013;72:229-34.
  12. Garcia-Doval I, Perez-Zafrilla B, Descalzo M A, et al. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis 2010;69:1751-5.
  13. Winthrop K L, Baddley J W, Chen L, et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA 2013;309:887-95.
  14. Yun H, Xie F, Delzell E, et al. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy. Arthritis Care Res (Hoboken) 2015;67:731-6.
  15. Asanuma H, Sharp M, Maecker H T, Maino VC, Arvin A M. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000;181:859-66.
  16. Schub D, Janssen E, Leyking S, et al. Altered Phenotype and Functionality of Varicella Zoster Virus-Specific Cellular Immunity in Individuals With Active Infection. J Infect Dis 2015;211:600-12.
  17. Laing K J, Russell R M, Dong L, et al. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis 2015;212:1022-31.
  18. Schmidt T, Adam C, Hirsch H H, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 2014;14:1334-45.
  19. Schmidt T, Sester M. Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry. Methods Mol Biol 2013;1064:267-74.